thioridazine has been researched along with Neuroleptic Malignant Syndrome in 20 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a fulminant case of Neuroleptic Malignant Syndrome in a 31-year-old male schizophrenic on haloperidol, thioridazine, benzhexol and flurazepam who presented with rigidity, fever, stupor and autonomic instability." | 3.69 | A fulminant case of neuroleptic malignant syndrome. ( Chew, WL; Lam, KN; Teo, SK, 1994) |
| " He developed neuroleptic malignant syndrome (NMS) which was treated successfully with intravenous diazepam." | 3.69 | Catatonic syndrome following recovery from neuroleptic malignant syndrome. ( Dent, J, 1995) |
| "Two cases are presented in which psychotic patients with neuroleptic malignant syndrome were treated with bromocriptine and thioridazine simultaneously, with a resulting control of both problems." | 3.67 | Concomitant treatment of neuroleptic malignant syndrome and psychosis. ( Goldwasser, HD; Hooper, JF; Spears, NM, 1989) |
| "To report a case of neuroleptic malignant syndrome (NMS) in a child, and review reports of 11 other paediatric cases of NMS." | 1.28 | Neuroleptic malignant syndrome in children. ( Numa, A, 1991) |
| "Two patients with primary hypothyroidism who developed neuroleptic malignant syndrome (NMS) are described." | 1.28 | Neuroleptic malignant syndrome and hypothyroidism. ( Blumhardt, LD; Macfarlane, IA; Moore, AP, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 11 (55.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imbach, M | 1 |
| Hess, Ch | 1 |
| Froesch, T | 1 |
| Yildiz, A | 1 |
| Alkin, T | 1 |
| Ozerdem, A | 1 |
| Sagduyu, K | 1 |
| Demopulos, CM | 1 |
| Nimmo, SM | 1 |
| Kennedy, BW | 1 |
| Tullett, WM | 1 |
| Blyth, AS | 1 |
| Dougall, JR | 1 |
| Teo, SK | 1 |
| Lam, KN | 1 |
| Chew, WL | 1 |
| Dent, J | 1 |
| Freedman, MD | 1 |
| Rao, KA | 1 |
| Adlakha, A | 1 |
| Meloy, T | 1 |
| Numa, A | 1 |
| Lazarus, A | 1 |
| Rosenberg, H | 1 |
| Teglia, MQ | 1 |
| Hopkins, TT | 1 |
| Cunha, BA | 1 |
| Kassirer, JP | 1 |
| Kopelman, RI | 1 |
| Kasckow, J | 1 |
| Dolor, R | 1 |
| Lipper, S | 1 |
| Moore, AP | 1 |
| Macfarlane, IA | 1 |
| Blumhardt, LD | 1 |
| Moysa, GD | 1 |
| Anisete, LV | 1 |
| Goldwasser, HD | 1 |
| Hooper, JF | 1 |
| Spears, NM | 1 |
| Aizenberg, D | 1 |
| Shalev, A | 1 |
| Munitz, H | 1 |
| Corrigan, FM | 1 |
| Coulter, F | 1 |
| Merriam, AE | 1 |
| Zammit, GK | 1 |
| Sullivan, TB | 1 |
| Chin, CN | 1 |
1 review available for thioridazine and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
Topics: Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Myocardial Infarc | 1997 |
19 other studies available for thioridazine and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
[Uncertain neurological status in a depressed patient].
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; H | 2002 |
Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
Topics: Acute-Phase Proteins; Adult; Antipsychotic Agents; Bromocriptine; Clopenthixol; Dopamine Agonists; E | 2003 |
Drug-induced hyperthermia.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Female; Fluoxetine; Humans; Male; Middle Aged; | 1993 |
A fulminant case of neuroleptic malignant syndrome.
Topics: Adult; Drug Therapy, Combination; Fatal Outcome; Haloperidol; Humans; Male; Neuroleptic Malignant Sy | 1994 |
Catatonic syndrome following recovery from neuroleptic malignant syndrome.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Chlorpromazine; Diazepam; Dose-Response Relati | 1995 |
Tremor, confusion, and autonomic dysfunction in Down syndrome.
Topics: Adult; Autonomic Nervous System Diseases; Confusion; Diagnosis, Differential; Down Syndrome; Haloper | 1992 |
Neuroleptic malignant syndrome in children.
Topics: Child; Humans; Male; Neuroleptic Malignant Syndrome; Thioridazine | 1991 |
Treatment of rehospitalized NMS patients.
Topics: Adult; Antipsychotic Agents; Fluphenazine; Follow-Up Studies; Humans; Male; Neuroleptic Malignant Sy | 1990 |
Neuroleptic malignant syndrome and Escherichia coli urosepsis.
Topics: Aged; Aged, 80 and over; Escherichia coli Infections; Humans; Incidence; Male; Neuroleptic Malignant | 1991 |
The accuracy of clinical information. 1. The history.
Topics: Adult; Female; Humans; Kidney Tubular Necrosis, Acute; Medical History Taking; Neuroleptic Malignant | 1991 |
Delayed onset of neuroleptic malignant syndrome after discontinuation of thioridazine.
Topics: Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Thioridazine; Time Factors | 1990 |
Neuroleptic malignant syndrome and hypothyroidism.
Topics: Adult; Brain; Female; Humans; Hypothyroidism; Middle Aged; Neuroleptic Malignant Syndrome; Obsessive | 1990 |
Neuroleptic malignant syndrome: successful rechallenge with thioridazine.
Topics: Adult; Antipsychotic Agents; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Thioridazi | 1989 |
Concomitant treatment of neuroleptic malignant syndrome and psychosis.
Topics: Adult; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Psychotic Disor | 1989 |
The aftercare of the patient with the neuroleptic malignant syndrome.
Topics: Adult; Aftercare; Basal Ganglia Diseases; Electroconvulsive Therapy; Humans; Male; Methotrimeprazine | 1985 |
Neuroleptic malignant syndrome, amitriptyline, and thioridazine.
Topics: Amitriptyline; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndr | 1988 |
Withdrawal NMS after drug treatment.
Topics: Amitriptyline; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Neuroleptic Malignant Syn | 1988 |
Thioridazine and neuroleptic malignant syndrome.
Topics: Female; Humans; Neuroleptic Malignant Syndrome; Thioridazine | 1987 |
Neuroleptic malignant syndrome: a case report.
Topics: Aged; Dementia; Drug Therapy, Combination; Female; Humans; Neuroleptic Malignant Syndrome; Thioridaz | 1986 |